Dn B Asset Management As Neurocrine Biosciences Inc Transaction History

Dn B Asset Management As

  • $19.9 Billion
  • Q2 2024

A detailed history of Dn B Asset Management As transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Dn B Asset Management As holds 74,946 shares of NBIX stock, worth $9.16 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
74,946
Previous 63,948 17.2%
Holding current value
$9.16 Million
Previous $8.82 Million 16.99%
% of portfolio
0.05%
Previous 0.05%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 05, 2024
BUY
$130.86 - $143.19 $1.44 Million - $1.57 Million
10,998 Added 17.2%
74,946 $10.3 Million
Q1 2024

Apr 12, 2024
SELL
$130.4 - $143.74 $247,108 - $272,387
-1,895 Reduced 2.88%
63,948 $8.82 Million
Q4 2023

Jan 04, 2024
SELL
$106.07 - $132.76 $1.51 Million - $1.88 Million
-14,189 Reduced 17.73%
65,843 $8.68 Million
Q3 2023

Oct 13, 2023
SELL
$94.02 - $117.1 $342,702 - $426,829
-3,645 Reduced 4.36%
80,032 $9 Million
Q2 2023

Jul 06, 2023
SELL
$89.53 - $104.87 $1.11 Million - $1.3 Million
-12,440 Reduced 12.94%
83,677 $7.89 Million
Q1 2023

Apr 20, 2023
BUY
$94.11 - $123.02 $889,904 - $1.16 Million
9,456 Added 10.91%
96,117 $9.73 Million
Q4 2022

Jan 12, 2023
SELL
$106.72 - $127.06 $117,925 - $140,401
-1,105 Reduced 1.26%
86,661 $10.4 Billion
Q3 2022

Oct 11, 2022
SELL
$92.03 - $107.81 $3.55 Million - $4.16 Million
-38,559 Reduced 30.52%
87,766 $9.32 Million
Q2 2022

Jul 08, 2022
SELL
$75.79 - $100.07 $669,149 - $883,518
-8,829 Reduced 6.53%
126,325 $12.3 Billion
Q1 2022

Apr 08, 2022
SELL
$72.45 - $94.81 $396,229 - $518,515
-5,469 Reduced 3.89%
135,154 $12.7 Million
Q4 2021

Jan 12, 2022
BUY
$79.65 - $106.22 $1.78 Million - $2.37 Million
22,344 Added 18.89%
140,623 $12 Million
Q3 2021

Oct 15, 2021
SELL
$86.18 - $99.03 $1.72 Million - $1.98 Million
-19,944 Reduced 14.43%
118,279 $11.3 Million
Q2 2021

Jul 06, 2021
BUY
$89.43 - $102.27 $1.74 Million - $1.99 Million
19,454 Added 16.38%
138,223 $13.5 Billion
Q1 2021

Apr 15, 2021
BUY
$87.57 - $119.4 $7.32 Million - $9.98 Million
83,562 Added 237.34%
118,769 $11.6 Million
Q4 2020

Jan 19, 2021
BUY
$86.91 - $108.33 $1.98 Million - $2.47 Million
22,831 Added 184.48%
35,207 $3.37 Million
Q2 2020

Jul 08, 2020
BUY
$85.09 - $130.36 $125,677 - $192,541
1,477 Added 13.55%
12,376 $1.51 Billion
Q1 2020

Apr 17, 2020
SELL
$75.11 - $113.76 $69,852 - $105,796
-930 Reduced 7.86%
10,899 $943,000
Q4 2019

Jan 13, 2020
BUY
$86.8 - $118.57 $1.03 Million - $1.4 Million
11,829 New
11,829 $1.27 Million

Others Institutions Holding NBIX

# of Institutions
641
Shares Held
95.3M
Call Options Held
661K
Put Options Held
227K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.7B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Dn B Asset Management As Portfolio

Follow Dn B Asset Management As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dn B Asset Management As, based on Form 13F filings with the SEC.

News

Stay updated on Dn B Asset Management As with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email